Canada Pension Plan Investment Board
FHTX icon

Canada Pension Plan Investment Board’s Foghorn Therapeutics FHTX Stock Holding History

Canada Pension Plan Investment Board’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$122K Hold
25,100
– – ﹤0.01% 1656
2026
Q1 		$120K Buy
25,100
+12,300
+96% +$67.5K ﹤0.01% 1640
2025
Q4 		$69.1K Buy
+12,800
New +$58K ﹤0.01% 1867

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
EC
Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Canada Pension Plan Investment Board's FHTX Position: Q2 2026 in Review

Canada Pension Plan Investment Board held its Foghorn Therapeutics (FHTX) position steady in Q2 2026 at 25,100 shares worth $122K. The position accounts for ﹤0.01% of the portfolio, ranked #1656.

Canada Pension Plan Investment Board first reported a position in FHTX in Q4 2025 and has held it in 3 quarters since. 102 funds tracked by Wall St. Rank hold FHTX as of Q2 2026.

  • Canada Pension Plan Investment Board held 25,100 shares of Foghorn Therapeutics worth $122K as of Q2 2026.
  • Canada Pension Plan Investment Board left its Foghorn Therapeutics share count unchanged in Q2 2026.
  • Foghorn Therapeutics made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1656 holding.
  • Canada Pension Plan Investment Board first reported a position in Foghorn Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 102 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.